CVS Health (CVS) Earnings Analysis
CVS Health (CVS) has no confirmed upcoming earnings date. Last quarter (2025-07-31) it beat with EPS 1.81 USD vs 1.46 USD est (+24%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E 46.79.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CVS next report earnings?
No confirmed upcoming earnings date is currently scheduled for CVS. This page updates as the calendar is published.
CVS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-07-31 | 1.81 USD | 1.46 USD | +24% | Beat |
| 2025-05-01 | 2.25 USD | 1.7 USD | +32.4% | Beat |
| 2025-02-12 | 1.19 USD | 0.914 USD | +30.2% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
CVS valuation and analyst view
| Trailing P/E | 46.79 |
|---|---|
| Trailing EPS | 2.303 USD |
| Price / book | 1.78 |
| Dividend yield | 2.46% |
| Market cap | 138.97B |
| Analyst consensus | Buy (35 buy / 6 hold / 0 sell) |
| Avg price target | 108.47 USD |
Related research pages
Frequently asked questions
When is CVS Health (CVS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for CVS. This page updates as the calendar is published.
Did CVS beat earnings last quarter?
In its 2025-07-31 report, CVS posted EPS of 1.81 USD versus a 1.46 USD estimate — a beat of 24%.
What is CVS's earnings track record?
Over the last 3 reported quarters with consensus data, CVS beat estimates 3 times (100%).
What is CVS's current P/E ratio and EPS?
CVS trades at a trailing P/E of 46.79 on trailing EPS of 2.3032207384131973 USD.
What do analysts rate CVS?
Analyst consensus is "Buy" across 41 ratings (2 strong buy, 33 buy, 6 hold, 0 sell, 0 strong sell). Average 12-month price target: 108.47 USD.